Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed with results

Key Signals

1 with results75% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (3)
P 4 (2)

Trial Status

Completed6
Terminated2
Unknown1
Active Not Recruiting1
Recruiting1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (11)

Research Network

Activity Timeline